Patents by Inventor Walter Gabriell Borelli Piedras

Walter Gabriell Borelli Piedras has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Materials for the Generation of Regulatory T Cells
    Publication number: 20210115401
    Abstract: Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25? T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed.
    Type: Application
    Filed: October 5, 2020
    Publication date: April 22, 2021
    Inventors: Tanja AARVAK, Anne-Marie RASMUSSEN, Gunnar KVALHEIM, Walter Gabriell Borelli PIEDRAS, Anne BRUNSVIG
  • METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
    Publication number: 20190071640
    Abstract: Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25? T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed.
    Type: Application
    Filed: August 7, 2018
    Publication date: March 7, 2019
    Inventors: Tanja AARVAK, Anne-Marie RASMUSSEN, Gunnar KVALHEIM, Walter Gabriell Borelli PIEDRAS, Anne BRUNSVIG
  • METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
    Publication number: 20160024470
    Abstract: Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25? T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed.
    Type: Application
    Filed: July 22, 2015
    Publication date: January 28, 2016
    Inventors: Tanja AARVAK, Anne-Marie RASMUSSEN, Gunnar KVALHEIM, Walter Gabriell Borelli PIEDRAS, Anne BRUNSVIG
  • Methods and materials for the generation of regulatory T cells
    Patent number: 9119807
    Abstract: Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25? T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: September 1, 2015
    Assignee: Life Technologies AS
    Inventors: Tanja Aarvak, Anne-Marie Rasmussen, Gunnar Kvalheim, Walter Gabriell Borelli Piedras, Anne Brunsvig
  • METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
    Publication number: 20100129340
    Abstract: Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25? T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed.
    Type: Application
    Filed: October 22, 2009
    Publication date: May 27, 2010
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Anne-Marie RASMUSSEN, Tanja Arvak, Gunnar Kvalheim, Walter Gabriell Borelli Piedras, Anne Brunsvig